UPB
Upstream Bio Inc.

278
Mkt Cap
$477.81M
Volume
225.00
52W High
$33.68
52W Low
$5.14
PE Ratio
-3.38
UPB Fundamentals
Price
$9.00
Prev Close
$8.78
Open
$9.01
50D MA
$15.49
Beta
1.23
Avg. Volume
2.38M
EPS (Annual)
-$2.66
P/B
1.44
Rev/Employee
$38,053.33
$1,121.86
Loading...
Loading...
News
all
press releases
Upstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, two h...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Upstream Bio (NASDAQ:UPB) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen lowered shares of Upstream Bio from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·4d ago
News Placeholder
Upstream Bio (NASDAQ:UPB) Downgraded by Evercore to In-Line
Evercore downgraded shares of Upstream Bio from an "outperform" rating to an "in-line" rating and set a $15.00 target price on the stock. in a research note on Friday...
MarketBeat·5d ago
News Placeholder
Upstream Bio Lead Drug Pivotal Trial Plan Follows Strong Phase 2 Data
Upstream Bio outlines Phase 3 plans for verekitug as asthma and CRSwNP data support dosing strategy; shares rise on update.read more...
Benzinga·6d ago
News Placeholder
Upstream Bio (NASDAQ:UPB) Posts Earnings Results, Misses Estimates By $0.06 EPS
Upstream Bio (NASDAQ:UPB - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.79) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.06). The company had revenue of $0.67 million for the quarter, compared to analyst...
MarketBeat·6d ago
News Placeholder
Upstream Bio (NASDAQ:UPB) Trading Up 11.2% - What's Next?
Upstream Bio (NASDAQ:UPB) Stock Price Up 11.2% - Here's Why...
MarketBeat·7d ago
News Placeholder
Upstream Bio (NASDAQ:UPB) Trading 14.4% Higher - Should You Buy?
Upstream Bio (NASDAQ:UPB) Stock Price Up 14.4% - What's Next...
MarketBeat·21d ago
News Placeholder
Upstream Bio (UPB) Expected to Announce Quarterly Earnings on Wednesday
Upstream Bio (NASDAQ:UPB) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...
MarketBeat·28d ago
News Placeholder
Upstream Bio, Inc. (NASDAQ:UPB) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Upstream Bio, Inc. (NASDAQ:UPB - Get Free Report) have been given an average rating of "Moderate Buy" by the five analysts that are presently covering the firm, MarketBeat.com reports. One...
MarketBeat·29d ago
News Placeholder
Upstream Bio Shares Phase II VALIANT Data: Verekitug Cuts Severe Asthma Exacerbations Up to 56%
Upstream Bio (NASDAQ:UPB) reported top-line results from its Phase II VALIANT trial evaluating verekitug in adults with severe asthma, highlighting statistically significant reductions in annualized...
MarketBeat·1mo ago
<
1
2
...
>

Latest UPB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.